Kingdom Financial Group LLC. Sells 1,423 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Kingdom Financial Group LLC. trimmed its position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 76.4% during the 1st quarter, according to its most recent 13F filing with the SEC. The fund owned 439 shares of the healthcare conglomerate's stock after selling 1,423 shares during the quarter. Kingdom Financial Group LLC.'s holdings in UnitedHealth Group were worth $230,000 at the end of the most recent reporting period.

Several other large investors have also bought and sold shares of UNH. Mirae Asset Global Investments Co. Ltd. lifted its position in UnitedHealth Group by 16.8% in the 1st quarter. Mirae Asset Global Investments Co. Ltd. now owns 133,697 shares of the healthcare conglomerate's stock valued at $67,504,000 after acquiring an additional 19,193 shares in the last quarter. Lafayette Investments Inc. increased its holdings in UnitedHealth Group by 13.9% in the 1st quarter. Lafayette Investments Inc. now owns 723 shares of the healthcare conglomerate's stock worth $379,000 after buying an additional 88 shares in the last quarter. Money Concepts Capital Corp lifted its stake in UnitedHealth Group by 36.8% during the 1st quarter. Money Concepts Capital Corp now owns 5,200 shares of the healthcare conglomerate's stock valued at $2,723,000 after acquiring an additional 1,400 shares during the period. Achmea Investment Management B.V. grew its stake in shares of UnitedHealth Group by 24.7% in the first quarter. Achmea Investment Management B.V. now owns 94,604 shares of the healthcare conglomerate's stock worth $49,549,000 after acquiring an additional 18,734 shares during the period. Finally, Waverton Investment Management Ltd lifted its position in UnitedHealth Group by 9.4% during the first quarter. Waverton Investment Management Ltd now owns 480,418 shares of the healthcare conglomerate's stock valued at $251,602,000 after purchasing an additional 41,441 shares during the period. 87.86% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In related news, CEO Stephen J. Hemsley bought 86,700 shares of the company's stock in a transaction dated Friday, May 16th. The stock was purchased at an average price of $288.57 per share, for a total transaction of $25,019,019.00. Following the acquisition, the chief executive officer now owns 679,493 shares in the company, valued at $196,081,295.01. This trade represents a 14.63% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Patrick Hugh Conway sold 589 shares of the firm's stock in a transaction on Tuesday, June 10th. The stock was sold at an average price of $305.00, for a total value of $179,645.00. Following the completion of the sale, the chief executive officer now owns 10,398 shares of the company's stock, valued at approximately $3,171,390. This represents a 5.36% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders acquired 109,408 shares of company stock valued at $31,607,768 in the last three months. Corporate insiders own 0.28% of the company's stock.

Wall Street Analyst Weigh In

A number of equities research analysts have weighed in on the stock. Wolfe Research decreased their target price on shares of UnitedHealth Group from $501.00 to $390.00 and set an "outperform" rating for the company in a research note on Tuesday, May 20th. Robert W. Baird downgraded UnitedHealth Group from an "outperform" rating to a "neutral" rating and set a $312.00 target price on the stock. in a report on Wednesday, June 11th. KeyCorp cut their price target on UnitedHealth Group from $450.00 to $400.00 and set an "overweight" rating for the company in a research note on Monday, June 2nd. Hsbc Global Res downgraded shares of UnitedHealth Group from a "hold" rating to a "moderate sell" rating in a report on Wednesday, May 21st. Finally, Mizuho decreased their price target on shares of UnitedHealth Group from $515.00 to $350.00 and set an "outperform" rating on the stock in a research report on Friday, May 16th. One analyst has rated the stock with a sell rating, nine have assigned a hold rating and sixteen have given a buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of "Moderate Buy" and an average price target of $415.57.

UnitedHealth Group Price Performance

Shares of NYSE:UNH traded up $6.23 during midday trading on Friday, reaching $308.85. 13,584,804 shares of the company were exchanged, compared to its average volume of 7,465,895. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.71. The stock has a market cap of $280.17 billion, a PE ratio of 12.93, a price-to-earnings-growth ratio of 1.43 and a beta of 0.44. The business's fifty day moving average is $336.21 and its two-hundred day moving average is $454.51. UnitedHealth Group Incorporated has a one year low of $248.88 and a one year high of $630.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.29% and a net margin of 5.39%. The firm had revenue of $109.58 billion during the quarter, compared to the consensus estimate of $111.56 billion. During the same period last year, the firm posted $6.91 earnings per share. As a group, analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, June 24th. Investors of record on Monday, June 16th were paid a dividend of $2.21 per share. This is an increase from UnitedHealth Group's previous quarterly dividend of $2.10. The ex-dividend date was Monday, June 16th. This represents a $8.84 dividend on an annualized basis and a yield of 2.86%. UnitedHealth Group's dividend payout ratio is presently 37.02%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.